Trial Profile
A study to evaluate the safety and efficacy of valsartan/amlodipine compared to lisinopril/hydrochlorothiazide given once daily for 6 weeks in patients with severe hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Lisinopril/hydrochlorothiazide
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 07 Nov 2011 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.